Hill Colin

Fulcrum Therapeutics, Inc. · Director

Hill Colin is listed in public filings as director. This Hill Colin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Fulcrum Therapeutics, Inc. (FULC). Investors use Hill Colin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Fulcrum Therapeutics, Inc.FULC$266k36k sharesGrant / ExerciseJun 26, 2025$265.7K36k shares$7.38--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Fulcrum Therapeutics, Inc.FULC$420k60k sharesGrant / ExerciseJun 17, 2024$420.0K60k shares$7.00--